Sobi Presents Update on State of Newborn Screening for HT-1 in the United States at APHL 2019 Newborn Screening and Genetic Testing Symposium
SWEDISH ORPHAN ADR (SWTUY)
NASDAQ:AMEX Investor Relations:
sobi.com/en/investors-and-media
Company Research
Source: Business Wire
WALTHAM, Mass.--(BUSINESS WIRE)-- Sobi, an international biopharmaceutical company transforming the lives of people affected by rare diseases, presented an update on the state of newborn screening for Hereditary Tyrosinemia Type 1 (HT-1) in the United States during the Association of Public Health Laboratories’ (APHL) 2019 Newborn Screening and Genetic Testing Symposium, April 7-10 in Chicago. HT-1 is an extremely rare but treatable hereditary disorder. If untreated, it can cause liver, renal and neurological complications.1 Newborn screening is essential to rapid diagnosis of HT-1, so that treatment can begin prior to significant disease progression, and HT-1 is included in the U.S. Department of Health and Human Services’ Recommended Uniform Screening Panel (RUSP).2 While elevated tyrosine was traditionally used as a diagnostic marker for HT-1, it has been shown not to be sufficiently specific nor sensitive
Show less
Read more
Impact Snapshot
Event Time:
SWTUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SWTUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SWTUY alerts
High impacting SWEDISH ORPHAN ADR news events
Weekly update
A roundup of the hottest topics